GlycoMimetics, Inc. - Common Stock (NQ:GLYC)

0.1570 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jun 13, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GlycoMimetics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Year-end 2022

March 29, 2023

From GlycoMimetics, Inc.

Via Business Wire

Earnings Preview For GlycoMimetics ↗

March 28, 2023

Via Benzinga

GlycoMimetics to Report Fourth Quarter and 2022 Full Year Financial Results on March 29, 2023

March 16, 2023

From GlycoMimetics, Inc.

Via Business Wire

Why Provention Bio Shares Are Trading Higher By Over 260%; Here Are 20 Stocks Moving Premarket ↗

March 13, 2023

Gainers Provention Bio, Inc. (NASDAQ: PRVB) rose 262.7% to $24.30 in pre-market trading after Sanofi agreed to acquire the company for $25.00 per share in cash, representing an equity value of...

Via Benzinga

GlycoMimetics to Participate in Upcoming Cowen 43rd Annual Health Care Conference

March 01, 2023

From GlycoMimetics, Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

February 21, 2023

Via Benzinga

$3M Bet On This Biotechnology Stock? Check Out These 3 Penny Stocks Insiders Are Buying ↗

February 21, 2023

The Dow Jones closed lower by over 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested...

Via Benzinga

Pagaya Technologies To Rally Around Over 120%? Here Are 10 Other Analyst Forecasts For Thursday ↗

February 16, 2023

Keybanc boosted the price target for Twilio Inc. (NYSE: TWLO) from $77 to $89. Keybanc analyst Thomas Blakey maintained an Overweight rating on the stock. Twilio shares gained 6.4% to close at $66.05...

Via Benzinga

GlycoMimetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

February 16, 2023

From GlycoMimetics, Inc.

Via Business Wire

Nasdaq Surges 90 Points; Credo Technology Group Shares Slide ↗

February 15, 2023

U.S. stocks turned mostly higher toward the end of trading, with the Nasdaq Composite gaining around 90 points on Wednesday. The Dow traded down 0.01% to 34,085.88 while the NASDAQ rose 0.76% to...

Via Benzinga

Gold Down 1%; Roblox Shares Spike Higher ↗

February 15, 2023

U.S. stocks traded mostly lower midway through trading, with the Dow Jones dropping over 100 points on Wednesday. The Dow traded down 0.34% to 33,974.46 while the NASDAQ rose 0.22% to 11,986.30. The...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

February 15, 2023

Via Benzinga

Why Sabre Are Trading Lower By 19%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

February 15, 2023

Gainers Sera Prognostics, Inc. (NASDAQ: SERA) shares surged 63.4% to $2.11 after the company announced top-line data from the AVERT PRETERM TRIAL.

Via Benzinga

Dow Dips 200 Points; US Retail Sales Rise 3% ↗

February 15, 2023

U.S. stocks traded lower this morning, with the Dow Jones dropping around 200 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.61% to 33,880.45 while the NASDAQ fell...

Via Benzinga

GlycoMimetics Announces Continuation of Phase 3 Study of E-selectin Antagonist Uproleselan in Relapsed/Refractory AML to Originally Planned Final Analysis Following Interim Analysis by Independent Data Monitoring Committee

February 15, 2023

From GlycoMimetics, Inc.

Via Business Wire

GlycoMimetics Audio Discussion And Analysis With Dan Cohen And Scott Matusow ↗

February 13, 2023

Dan Cohen and Scott Matusow discuss In this 1:11 audio the upcoming data sets for Glycomimetics. We talk about The Company's platform chemistry in depth, and give our predictions for success/failure of...

Via Talk Markets

GlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

February 06, 2023

From GlycoMimetics, Inc.

Via Business Wire

Top 5 Health Care Stocks That May Dip ↗

January 27, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

GlycoMimetics And 3 Other Stocks Under $3 Insiders Are Aggressively Buying ↗

December 28, 2022

The Dow Jones settled slightly higher on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around...

Via Benzinga

US Stocks Rise; Dow Gains 100 Points ↗

December 28, 2022

U.S. stocks traded higher this morning, with the Dow Jones gaining over 100 points on Wednesday.

Via Benzinga

Why Shares Of Chinese Companies Are Trading Lower? Here Are 54 Stocks Moving In Wednesday's Mid-Day Session ↗

December 28, 2022

Gainers Kala Pharmaceuticals, Inc. (NASDAQ: KALA) shares gained 130.5% to $9.03 after the company announced FDA acceptance of a IND application for its KPI-012 for the treatment of persistent corneal...

Via Benzinga

Why Third Harmonic Bio Shares Are Trading Lower By Over 78%? Here Are 40 Stocks Moving In Thursday's Mid-Day Session ↗

December 15, 2022

Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) jumped 69.6% to $0.2604 after gaining 17% on Wednesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

December 15, 2022

It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Thursday!

Via InvestorPlace

Why Planet Labs Shares Are Trading Higher; Here Are 28 Stocks Moving Premarket ↗

December 15, 2022

Gainers Scopus BioPharma Inc. (NASDAQ: SCPS) shares rose 74.7% to $0.4104 in pre-market trading after declining 4% on Wednesday.

Via Benzinga

GlycoMimetics Announces New Uproleselan Clinical Data in Both Frontline Unfit and Treated Secondary Acute Myeloid Leukemia presented at ASH Annual Meeting

December 12, 2022

From GlycoMimetics, Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

December 02, 2022

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

November 21, 2022

Via Benzinga

Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday ↗

November 15, 2022

Gainers Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus...

Via Benzinga

Why Tattooed Chef Shares Dipped Around 15%; Here Are 95 Biggest Movers From Friday ↗

November 14, 2022

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 56.6% to settle at $19.10 on Friday.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

November 11, 2022

Gainers

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.